World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
54
Citations
8647
World Ranking
15797
National Ranking
438

Overview

Doug A. Brooks is affiliated with the University of South Australia in Australia and has conducted extensive research primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their main subfields of study include Molecular Biology, Immunology, Oncology, Cancer Research, and Pulmonary and Respiratory Medicine.

The scientist's research focuses on several interconnected topics. These include Cancer Cells and Metastasis, Prostate Cancer Treatment and Research, Influenza Virus Research Studies, Birth, Development, and Health, Immune Response and Inflammation, Cancer, Lipids, and Metabolism, as well as Crystallization and Solubility Studies.

Among their recent scholarly contributions are the following papers:

  • Platelets, immune cells and the coagulation cascade; friend or foe of the circulating tumour cell?, 2021, Molecular Cancer
  • Fluorescence Microscopy-An Outline of Hardware, Biological Handling, and Fluorophore Considerations, 2021, Cells
  • Influenza A virus causes maternal and fetal pathology via innate and adaptive vascular inflammation in mice, 2020, Proceedings of the National Academy of Sciences
  • Targeting Evolutionary Conserved Oxidative Stress and Immunometabolic Pathways for the Treatment of Respiratory Infectious Diseases, 2020, Antioxidants and Redox Signaling
  • Glycolysis and the Pentose Phosphate Pathway Promote LPS-Induced NOX2 Oxidase- and IFN-β-Dependent Inflammation in Macrophages, 2022, Antioxidants

Doug A. Brooks frequently collaborates with several coauthors, including:

  • John O'Leary
  • Robert D. Brooks
  • Stavros Selemidis
  • Shane M. Hickey
  • Alexandra Sorvina

The scientist has published numerous articles in several scholarly venues, with higher publication counts in:

  • The Cambridge Structural Database
  • International Journal of Molecular Sciences
  • Cells
  • Journal of Biophotonics
  • Scientific Reports

Best Publications

  • Mutations in UPF3B , a member of the nonsense-mediated mRNA decay complex, cause syndromic and nonsyndromic mental retardation

    Patrick S. Tarpey;F. Lucy Raymond;Lam S. Nguyen;Jayson Rodriguez

  • Lysosomal Storage Disease: Revealing Lysosomal Function and Physiology

    Emma J. Parkinson-Lawrence;Tetyana Shandala;Mark Prodoehl;Revecca Plew

  • Intestinal fructose transport and malabsorption in humans

    Hilary F. Jones;Ross N. Butler;Doug A. Brooks

  • Gentamicin-mediated suppression of Hurler syndrome stop mutations restores a low level of alpha-L-iduronidase activity and reduces lysosomal glycosaminoglycan accumulation.

    Kim M. Keeling;Doug A. Brooks;John J. Hopwood;Peining Li

  • Newborn screening for lysosomal storage disorders

    Peter J. Meikle;Dallas J. Grasby;Caroline J. Dean;Debbie L. Lang

  • Syntaxin 7 is localized to late endosome compartments, associates with Vamp 8, and Is required for late endosome-lysosome fusion.

    Barbara M. M Mullock;Chez W. Smith;Gudrun Ihrke;Nicholas A. Bright

  • Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. IV. A monoclonal antibody reacting specifically with a subpopulation of human B lymphocytes.

    D A Brooks;I G Beckman;J Bradley;P J McNamara

  • Mutational analysis of 105 mucopolysaccharidosis type VI patients

    Litsa Karageorgos;Doug A. Brooks;Anthony Pollard;Elizabeth L. Melville

  • Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. I. A hybridoma secreting antibody against a marker specific for human B lymphocytes.

    D A Brooks;I Beckman;J Bradley;P J McNamara

  • Diagnosis of lysosomal storage disorders: evaluation of lysosome-associated membrane protein LAMP-1 as a diagnostic marker

    Peter J. Meikle;Doug A. Brooks;Elaine M. Ravenscroft;Miao Yan

  • Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis I

    Revecca Kakavanos;Chris T Turner;John J Hopwood;Emil D Kakkis

  • Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome.

    Allison C. Crawley;Doug A. Brooks;Vivienne J. Muller;Birgit A. Petersen

  • Endosomal NOX2 oxidase exacerbates virus pathogenicity and is a target for antiviral therapy

    Eunice E. To;Eunice E. To;Ross Vlahos;Raymond Luong;Michelle L. Halls

  • Significance of immune response to enzyme-replacement therapy for patients with a lysosomal storage disorder

    Doug A. Brooks;Revecca Kakavanos;John J. Hopwood

  • α-l-Iduronidase Premature Stop Codons and Potential Read-Through in Mucopolysaccharidosis Type I Patients

    Leanne K Hein;Michael Bawden;Michael Bawden;Vivienne J Muller;Vivienne J Muller;David Sillence

  • Stop-codon read-through for patients affected by a lysosomal storage disorder

    Doug A. Brooks;Viv J. Muller;John J. Hopwood

  • Chromosomal localization of the human alpha-L-iduronidase gene (IDUA) to 4p16.3.

    H S Scott;L J Ashton;H J Eyre;E Baker

  • Lysosomal biogenesis in lysosomal storage disorders.

    Litsa E. Karageorgos;Elizabeth L. Isaac;Doug A. Brooks;Elaine M. Ravenscroft

  • α‐L‐iduronidase mutations (Q70X and P533R) associate with a severe Hurler phenotype

    Hamish S. Scott;Tom Litjens;Paul V. Nelson;Doug A. Brooks

  • The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature.

    Doug A Brooks;Murray F. Brennan;Helen J Lewis;W Bowne

Frequent Co-Authors

John J. Hopwood
John J. Hopwood University of Adelaide
Peter J. Meikle
Peter J. Meikle Baker IDI Heart and Diabetes Institute
Ross L. Tellam
Ross L. Tellam Commonwealth Scientific and Industrial Research Organisation
Ross Vlahos
Ross Vlahos RMIT University
Steven Bozinovski
Steven Bozinovski RMIT University
John D. Hayball
John D. Hayball University of South Australia
Christoph Peters
Christoph Peters University of Freiburg
Lisa M. Butler
Lisa M. Butler University of Adelaide
Hamish S. Scott
Hamish S. Scott University of Adelaide
Christopher J.H. Porter
Christopher J.H. Porter Monash University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry opens doors to numerous online degree options and career pathways in the health and life sciences fields. Many students transition into areas such as medical coding, billing, health information management, or nutrition—all of which are in high demand and offer online learning flexibility.

A popular option is becoming a medical coder. Understanding the medical coder salary can help you gauge the earning potential in this rapidly growing field. If you are considering this route, it’s important to consider is medical billing and coding a good career for you, examining both advantages and challenges.

For those focused on patient data and healthcare systems, consider enrolling in an online health information management degree. This pathway is ideal for students interested in the organization and management of healthcare data.

Another in-demand field is nutrition. Advancing your expertise through an online nutrition masters can open careers in healthcare, research, or wellness coaching.

Best Scientists Citing Doug A. Brooks

Trending Scientists

Recently Published Articles